skip to main content

H.R. 2866 (111th): Improving Access to Clinical Trials Act of 2009

To provide for a disregard under the Supplemental Security Income program of compensation for participation in clinical trials for rare diseases or conditions.

The bill’s titles are written by its sponsor.

Overview

Introduced:

Jun 15, 2009
111th Congress, 2009–2010

Status:
Introduced (Enacted Via Other Measures)

Provisions of this bill were incorporated into other bills which were enacted.

Provisions of this bill also appear in:

S. 1674: Improving Access to Clinical Trials Act of 2009
Enacted — Signed by the President on Oct 5, 2010. (compare text)
Sponsor:

Edward “Ed” Markey

Representative for Massachusetts's 7th congressional district

Democrat

Text:

Read Text »
Last Updated: Jun 15, 2009
Length: 5 pages

History

Jun 15, 2009
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

H.R. 2866 (111th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

This bill was introduced in the 111th Congress, which met from Jan 6, 2009 to Dec 22, 2010. Legislation not enacted by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2866 — 111th Congress: Improving Access to Clinical Trials Act of 2009.” www.GovTrack.us. 2009. August 21, 2017 <https://www.govtrack.us/congress/bills/111/hr2866>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.